Our most advanced energy-based skin health platforms are currently being prepared for launch by independently-funded companies purpose-built to commercialize assets developed at Blossom Innovations. Led by experienced commercial teams, and with our founders as active leaders, R2 Technologies and AVAVA, Inc. are currently advancing two of our leading platforms to success in thriving global markets.
Simultaneously, we’re internally pursuing the launch of a breakthrough injection targeting system through our wholly-owned company S3Inject, using our own robust in-house product development resources.